We aimed to investigate the regulatory impact of ceRNA composed of NR2F1-AS1/miR-190a/PHLDB2 on the EMT of GC as well as the relationship and mechanism between ceRNA, the AKT pathway, and GC cell EMT. This evidence concerns the gene NR2F1 and gastric cancer.